Growing community of inventors

South Pasadena, CA, United States of America

Sarah Reisman

Average Co-Inventor Count = 3.66

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Sarah ReismanChen Xu (2 patents)Sarah ReismanKangway V Chuang (2 patents)Sarah ReismanRoland Goetz (1 patent)Sarah ReismanWilliam M Clemons, Jr (1 patent)Sarah ReismanStephan Zuend (1 patent)Sarah ReismanMartin John Mclaughlin (1 patent)Sarah ReismanKyoung-Soon Jang (1 patent)Sarah ReismanElliot P Farney (1 patent)Sarah ReismanRoger Nani (1 patent)Sarah ReismanSean S Feng (1 patent)Sarah ReismanSergiy Levin (1 patent)Sarah ReismanMichael Rombola (1 patent)Sarah ReismanCarolyn L Ladd (1 patent)Sarah ReismanSarah Reisman (5 patents)Chen XuChen Xu (8 patents)Kangway V ChuangKangway V Chuang (2 patents)Roland GoetzRoland Goetz (38 patents)William M Clemons, JrWilliam M Clemons, Jr (4 patents)Stephan ZuendStephan Zuend (4 patents)Martin John MclaughlinMartin John Mclaughlin (3 patents)Kyoung-Soon JangKyoung-Soon Jang (1 patent)Elliot P FarneyElliot P Farney (1 patent)Roger NaniRoger Nani (1 patent)Sean S FengSean S Feng (1 patent)Sergiy LevinSergiy Levin (1 patent)Michael RombolaMichael Rombola (1 patent)Carolyn L LaddCarolyn L Ladd (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. California Institute of Technology (5 from 4,554 patents)

2. Basf Corporation (1 from 2,036 patents)


5 patents:

1. 11926589 - Process for the synthesis of non-racemic cyclohexenes

2. 10626099 - Process for preparing pleuromutilin

3. 10392360 - Synthetic route to anhydroryanodol, ryanodol and structural analogues

4. 9862696 - Synthetic route to anhydroryanodol, ryanodol and structural analogues

5. 9541558 - Cysteine hydrazide nicotinamide for glycomics and glycoproteomics uses

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…